Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.
Iwabu M
,
Yamauchi T
,
Okada-Iwabu M
,
Sato K
,
Nakagawa T
,
Funata M
,
Yamaguchi M
,
Namiki S
,
Nakayama R
,
Tabata M
,
Ogata H
,
Kubota N
,
Takamoto I
,
Hayashi YK
,
Yamauchi N
,
Waki H
,
Fukayama M
,
Nishino I
,
Tokuyama K
,
Ueki K
,
Oike Y
,
Ishii S
,
Hirose K
,
Shimizu T
,
Touhara K
,
Kadowaki T
.
???displayArticle.abstract???
Adiponectin is an anti-diabetic adipokine. Its receptors possess a seven-transmembrane topology with the amino terminus located intracellularly, which is the opposite of G-protein-coupled receptors. Here we provide evidence that adiponectin induces extracellular Ca(2+) influx by adiponectin receptor 1 (AdipoR1), which was necessary for subsequent activation of Ca(2+)/calmodulin-dependent protein kinase kinase beta (CaMKKbeta), AMPK and SIRT1, increased expression and decreased acetylation of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), and increased mitochondria in myocytes. Moreover, muscle-specific disruption of AdipoR1 suppressed the adiponectin-mediated increase in intracellular Ca(2+) concentration, and decreased the activation of CaMKK, AMPK and SIRT1 by adiponectin. Suppression of AdipoR1 also resulted in decreased PGC-1alpha expression and deacetylation, decreased mitochondrial content and enzymes, decreased oxidative type I myofibres, and decreased oxidative stress-detoxifying enzymes in skeletal muscle, which were associated with insulin resistance and decreased exercise endurance. Decreased levels of adiponectin and AdipoR1 in obesity may have causal roles in mitochondrial dysfunction and insulin resistance seen in diabetes.
Anderson,
Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta.
1998, Pubmed
Anderson,
Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta.
1998,
Pubmed
Berchtold,
Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease.
2000,
Pubmed
Berg,
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.
2001,
Pubmed
Fruebis,
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.
2001,
Pubmed
Guarente,
Sirtuins as potential targets for metabolic syndrome.
2006,
Pubmed
Handschin,
The role of exercise and PGC1alpha in inflammation and chronic disease.
2008,
Pubmed
Handschin,
Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals.
2007,
Pubmed
Hawley,
Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase.
1996,
Pubmed
Hawley,
Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase.
2005,
Pubmed
Henstridge,
Adiponectin sparks an interest in calcium.
2010,
Pubmed
Hotamisligil,
Inflammation and metabolic disorders.
2006,
Pubmed
Hotta,
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.
2000,
Pubmed
Houstis,
Reactive oxygen species have a causal role in multiple forms of insulin resistance.
2006,
Pubmed
Hu,
AdipoQ is a novel adipose-specific gene dysregulated in obesity.
1996,
Pubmed
Jäger,
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha.
2007,
Pubmed
Kahn,
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.
2005,
Pubmed
Kersten,
Roles of PPARs in health and disease.
2000,
Pubmed
Kubota,
Disruption of adiponectin causes insulin resistance and neointimal formation.
2002,
Pubmed
Maeda,
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).
1996,
Pubmed
Maeda,
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.
2002,
Pubmed
Mootha,
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.
2003,
Pubmed
Mootha,
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.
2004,
Pubmed
Nakano,
Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma.
1996,
Pubmed
Patti,
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.
2003,
Pubmed
Petersen,
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
2004,
Pubmed
Rodgers,
Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.
2005,
Pubmed
Scheer,
Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.
1996,
Pubmed
Scherer,
A novel serum protein similar to C1q, produced exclusively in adipocytes.
1995,
Pubmed
Shkryl,
Transfer and tunneling of Ca2+ from sarcoplasmic reticulum to mitochondria in skeletal muscle.
2006,
Pubmed
Soderling,
The Ca-calmodulin-dependent protein kinase cascade.
1999,
Pubmed
St-Pierre,
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.
2006,
Pubmed
Tokumitsu,
STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase.
2002,
Pubmed
Tomas,
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
2002,
Pubmed
Tóth,
Quantitative assessment of [Ca2+]i levels in rat skeletal muscle in vivo.
1998,
Pubmed
Um,
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.
2004,
Pubmed
Wang,
Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1.
2007,
Pubmed
Wess,
G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition.
1997,
Pubmed
Woods,
Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.
2005,
Pubmed
Wu,
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.
2000,
Pubmed
Wu,
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.
1999,
Pubmed
Yamauchi,
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.
2001,
Pubmed
Yamauchi,
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.
2002,
Pubmed
Yamauchi,
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.
2003,
Pubmed
Yamauchi,
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.
2003,
Pubmed
Yamauchi,
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.
2007,
Pubmed
Yokomizo,
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis.
1997,
Pubmed
